Wanyuan Liang
Overview
Explore the profile of Wanyuan Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Chen C, Chen Q, Yuan S, Liang W, Zhu Y, et al.
Psychiatry Res
. 2024 Apr;
336:115917.
PMID: 38663222
The relationship between the use of selective serotonin reuptake inhibitors (SSRIs) and suicide risk in patients with mental disorders remains controversial. We conducted a network meta-analysis to examine the effects...
2.
Li J, Deng C, Liang W, Kang F, Bai Y, Ma B, et al.
Bioact Mater
. 2021 Apr;
6(11):3839-3850.
PMID: 33898880
Osteoporosis is caused by an osteoclast activation mechanism. People suffering from osteoporosis are prone to bone defects. Increasing evidence indicates that scavenging reactive oxygen species (ROS) can inhibit receptor activator...
3.
Zhong X, Ouyang C, Liang W, Dai C, Zhang W
Neuropsychiatr Dis Treat
. 2021 Feb;
17:297-304.
PMID: 33568909
Purpose: Learning impairment after electroconvulsive therapy (ECT) is common. Ketamine, an anesthetic used for ECT, has been demonstrated to attenuate cognitive impairment after ECT. However, the mechanism by which ketamine...
4.
Zhong X, Liao Y, Chen X, Mai N, Ouyang C, Chen B, et al.
Front Neurosci
. 2020 Oct;
14:859.
PMID: 33013289
Background: Our previous study in animal models revealed that bilirubin could induce Aβ formation and deposition. Bilirubin may be important in neurodegenerative dementia with Aβ deposition. Hence, lowering the concentration...
5.
Zhou H, Zhong X, Chen B, Wu Z, Zhang M, Mai N, et al.
J Affect Disord
. 2020 Aug;
277:212-217.
PMID: 32829197
Background: Both an elevated homocysteine (Hcy) level and depression are risk factors for cognitive impairment in the general population, but no study has analyzed whether the coexistence of an elevated...
6.
Zhang M, Zhong X, Shi H, Vanmechelen E, De Vos A, Liu S, et al.
J Alzheimers Dis
. 2020 Aug;
77(1):313-322.
PMID: 32804135
Background: Patients with spirochetal infection, which causes neurosyphilis (NS) and at a later stage general paresis of the insane (GPI), present with brain pathology features of Alzheimer's disease (AD). However,...
7.
Dong R, Bai Y, Dai J, Deng M, Zhao C, Tian Z, et al.
J Tissue Eng
. 2020 Jun;
11:2041731420926918.
PMID: 32551034
Recently, extracellular matrix-based tissue-engineered bone is a promising approach to repairing bone defects, and the seed cells are mostly mesenchymal stem cells. However, bone remodelling is a complex biological process,...
8.
Zhong X, Wu Z, Ouyang C, Liang W, Chen B, Peng Q, et al.
Int Psychogeriatr
. 2019 Jan;
31(10):1483-1489.
PMID: 30696513
Objectives: Cognitive impairment in late-life depression is common and associated with a higher risk of all-cause dementia. Late-life depression patients with comorbid cardiovascular diseases (CVDs) or related risk factors may...
9.
Chen B, Zhong X, Mai N, Peng Q, Zhang M, Chen X, et al.
J Alzheimers Dis
. 2018 Nov;
66(4):1645-1655.
PMID: 30475771
Olfactory identification (OI) deficits have been regarded as an indicator of cognitive impairment in the elderly, but few studies have analyzed the mixed effect of depression on OI. Since depression...
10.
Zhong X, Ning Y, Gu Y, Wu Z, Ouyang C, Liang W, et al.
J Affect Disord
. 2018 Aug;
240:214-219.
PMID: 30081292
Background: Late-life depression is a risk factor of dementia. It may increase the risk of reliable cognitive decline in the short term, and its associated risk factors remain unclear. Cortisol...